SAXAGLIPTIN / METFORMIN (Komboglyze®)
Clinical Indication
Type 2 Diabetes
Date of classification
June 2015
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.